Purpose: To examine associations between surgical technique, patient a
nd surgeon characteristics, and clinical outcomes of cataract surgery.
Methods: Seventy-five ophthalmologists were recruited from three citi
es based on a sampling scheme stratified by surgeon-reported annual vo
lume of cataract surgery. Seven hundred seventy-two patients undergoin
g first eye cataract surgery were enrolled, with complete preoperative
, perioperative, and 4-month postoperative clinical data on 717 patien
ts (93%). Results: Sixty-five percent of surgery was performed by phac
oemulsification and 35% by standard extracapsular (ECCE) techniques. P
erformance of ECCE was associated with the presence of ocular comorbid
ity and 21 or more years in practice of the surgeon. Performance of ph
acoemulsification was associated with annual volume of cataract surger
y, wherein high-volume (201-399 patients annually) and very high-volum
e (>400 patients annually) surgeons had 3.7 and 3.9 times the likeliho
od of performing phacoemulsification compared with moderate-volume (51
-200 cases annually) surgeons. The rates of intraoperative, perioperat
ive, and 4-month postoperative adverse events and the amount of improv
ement in visual acuity did not differ either by surgical technique or
volume stratum. The reported occurrence of posterior capsular opacific
ation within 4 months of surgery was increased in the presence of cort
ical opacification, one city, and patients operated on by either high-
or very high-volume surgeons. Conclusions: in this cohort, no differe
nce in clinical outcomes, as measured by change in visual acuity or oc
currence of postoperative adverse events (except for posterior capsula
r opacification), can be attributed to performance of phacoemulsificat
ion versus ECCE or to the reported annual volume of cataract surgery o
f the surgeon. Self-reported high and very high annual volume of catar
act surgery is associated independently with performance of phacoemuls
ification and surgeon's report of posterior capsular opacification at
4 months after cataract surgery.